Who owns Cumberland Pharmaceuticals?
- Ticker: CPIX
- CUSIP Number: 230770109
Tip: Access positions for across all investors
Analyze quarterly positions in Cumberland Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cumberland Pharmaceuticals stock
Who bought or sold Cumberland Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 503k | $3.3M | -9% | Jun 2026 |
|
| Renaissance Technologies | 478k | $3.1M | 2% | Jun 2026 |
|
| Vanguard Capital Management | 380k | $2.5M | 5% | Jun 2026 |
|
| Susquehanna International | 280k | $1.8M | 281% | Jun 2026 |
|
| Dimensional Fund Advisors | 233k | $1.5M | -16% | Jun 2026 |
|
| Boothbay Fund Management | 113k | $729k | -12% | Jun 2026 |
|
| Jane Street | 112k | $723k | 90% | Jun 2026 |
|
| Geode Capital Management | 108k | $703k | -5% | Jun 2026 |
|
| Perceptive Advisors | 97k | $628k | -51% | Jun 2026 |
|
| Citadel Advisors | 97k | $625k | 94% | Jun 2026 |
|
| BlackRock | 64k | $412k | 12% | Jun 2026 |
|
| Bank of New York Mellon | 59k | $379k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 55k | $356k | 20% | Jun 2026 |
|
| State Street Corporation | 40k | $128k | 17% | Mar 2026 |
|
| UBS Group | 26k | $171k | 408% | Jun 2026 |
|
| Bridgeway Capital Management | 26k | $170k | -84% | Jun 2026 |
|
| Bailard | 25k | $160k | 100% | Jun 2026 |
|
| Quadrature Capital | 24k | $156k | 100% | Jun 2026 |
|
| Two Sigma Investments | 24k | $155k | 116% | Jun 2026 |
|
| Northern Trust | 22k | $142k | 12% | Jun 2026 |
|
| Arrowstreet Capital, Limited Partnership | 20k | $131k | 0% | Jun 2026 |
|
| Cresset Asset Management | 20k | $126k | 0% | Jun 2026 |
|
| XTX Topco | 14k | $92k | -41% | Jun 2026 |
|
| Simplex Trading | 4.5k | $29k | 100% | Jun 2026 |
|
| Morgan Stanley | 3.3k | $11k | 0% | Mar 2026 |
|
| Capital Advisors | 437.00 | $3.0k | 0% | Jun 2026 |
|
| Institute For Wealth Management | 352.00 | $2.3k | 100% | Jun 2026 |
|
| Advisor Group Holdings | 200.00 | $1.3k | 100% | Jun 2026 |
|
| Tower Research Capital | 191.00 | $1.2k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 100.00 | $648.000000 | 0% | Jun 2026 |
|
| Barclays | 48.00 | $311.001600 | 100% | Jun 2026 |
|
| FMR | 21.00 | $136.000200 | 100% | Jun 2026 |
|
| Huntington National Bank | 1.00 | $6.000000 | 0% | Jun 2026 |
|
Who sold out of Cumberland Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| J. Goldman & Co | Mar 2026 | 81k | $263k |
| Acadian Asset Management | Mar 2026 | 44k | $143k |
| Marex Group | Mar 2026 | 36k | $118k |
| Royal Bank of Canada | Mar 2026 | 127.00 | $0 |
| Caitong International Asset Management | Mar 2026 | 2.00 | $6.000000 |